-
From Pyroptosis to Apoptosis: A Caspase-9 Strategy
2026-08-19
Z-LEHD-FMK, an irreversible caspase-9 inhibitor, helps translational researchers distinguish mitochondria-mediated apoptosis from caspase-1-driven pyroptosis. This article connects mechanistic pathway mapping with assay design, model selection, and translational decision-making.
-
Biomimetic mRNA Nanovaccines Target Neutrophils
2026-08-19
Li et al. developed a biomimetic mRNA nanovaccine that uses CD300LD-decorated tumor cell membranes to direct IL-36γ expression toward tumor-associated neutrophils in hepatocellular carcinoma. The preclinical findings suggest that selectively reprogramming neutrophils can complement conventional immunotherapy, while also highlighting important questions about receptor specificity, cytokine safety, and translation beyond mouse tumor models.
-
Chemerin, cNTS, and Sympathetic Blood Pressure Control
2026-08-18
This 2024 study identifies a previously underdefined chemerin-CMKLR1 redox pathway in the caudal nucleus tractus solitarius that increases sympathetic activity, arterial pressure, and heart rate. Its pharmacological experiments further place NMDA-receptor signaling in the paraventricular nucleus downstream of this pathway, while CNQX-sensitive AMPA/kainate transmission was not required under the tested conditions.
-
Stiripentol: LDH Inhibition in Metabolic Research
2026-08-18
Stiripentol is a chemically distinct LDH inhibitor for connecting lactate flux with neuronal excitability, histone lactylation, and immune function. This workflow-focused guide shows how to prepare, dose, validate, and troubleshoot Stiripentol experiments in epilepsy and tumor-immunometabolism models.
-
Doxycycline hyclate for BBB and MMP Research
2026-08-17
Doxycycline hyclate is a practical matrix metalloproteinases inhibitor for connecting MMP-2/MMP-9 activity with blood-brain barrier failure, neuronal apoptosis, and cognitive phenotypes. This guide translates a mouse neurotoxicity study into controlled formulation, dosing, assay, and troubleshooting workflows.
-
Caspofungin: From Target to Assay Insight
2026-08-16
Caspofungin is a lipopeptide antifungal drug whose glucan-synthase inhibition provides a powerful framework for interpreting Candida phenotypes. This article connects molecular mechanism, resistance-aware assay design, and the delayed-treatment findings from a key Candida auris study.
-
Salvianolic Acid B: LH2 Workflow for Fibrosis
2026-08-15
Salvianolic acid B, also called Dan Shen Suan B, provides a mechanism-led workflow for studying LH2-dependent collagen remodeling in pulmonary fibrosis models. This guide translates the reference findings into practical cell-based assays, matrix readouts, and troubleshooting steps for reproducible natural-product research.
-
LINC02870 Drives SNAIL Translation in HCC
2026-08-14
The reference study identifies LINC02870 as a potentially oncogenic long non-coding RNA that promotes hepatocellular carcinoma progression by engaging EIF4G1 and increasing SNAIL translation. Its combination of clinical expression analysis, prognostic modeling, cellular perturbation, and mechanistic investigation provides a useful framework for studying lncRNA control of translation in HBV-associated HCC.
-
AAPH: Translating Lipid Peroxidation into Insight
2026-08-14
A mechanistic and strategic guide to using AAPH as a controlled reactive oxygen species generator, erythrocyte hemolysis inducer, and in vitro oxidative damage model—while connecting assay design to emerging PRDX6–GPX4 ferroptosis biology.
-
Azilsartan medoxomil monopotassium: AT1 Research
2026-08-13
Azilsartan medoxomil monopotassium, also known as TAK 491, supports receptor-binding, functional signaling, and translational blood-pressure workflows. Its strong AT1 selectivity and sustained washout profile make it useful for connecting mechanistic assays with cardiovascular and renal research models.
-
Salvianolic Acid B Targets LH2 in Pulmonary Fibrosis
2026-08-13
The reference study identifies Salvianolic acid B as a modulator of LH2/PLOD2-associated collagen cross-linking in pulmonary fibrosis. Its experiments connect LH2 suppression with reduced fibrotic remodeling, epithelial–mesenchymal transition, fibroblast activation, and Wnt/β-catenin signaling, while also defining important questions for translational validation.
-
Affinity-Purified Goat Anti-Rabbit IgG (H+L) Guide
2026-08-12
Build more reproducible Western blot, ELISA, IHC, and immunocytochemistry workflows with an affinity-purified HRP secondary designed for rabbit IgG detection. This practical guide connects assay design, signal amplification, storage, and troubleshooting to a neuroinflammation and neuroplasticity study framework.
-
Pexidartinib: A CSF1R Tool for Microglia Assays
2026-08-12
Pexidartinib (PLX3397) provides a targeted way to interrogate CSF1R-dependent microglial biology rather than relying only on descriptive markers. This article translates recent alcohol-induced seizure findings into a rigorous assay strategy while defining the limits of extending tumor-macrophage pharmacology to neuroscience.
-
Salvianolic Acid B and the LH2 Fibrosis Axis
2026-08-11
Salvianolic acid B is emerging as a mechanistically informative natural product for fibrosis studies, with evidence linking reduced LH2 expression to altered collagen cross-linking, extracellular matrix remodeling, and pulmonary fibrotic progression. This article translates that biology into practical experimental and translational guidance while distinguishing established findings from strategic opportunities.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-10
Zhao and colleagues present a standardized ex vivo whole-blood stimulation protocol that combines immune challenges with targeted metabolic inhibition. The workflow preserves blood-cell interactions while enabling cytokine-based evaluation of how anabolic and catabolic pathways selectively shape immune responses.
459 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page